Covishield | Page 3 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
April 01, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, APRIL 01, 2026

Covishield

Covishield

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

India revises 2nd dose interval for Covishield to 4-8 weeks

"Keeping the existing scientific evidence in view, it appears that protection is enhanced if the second dose of Covishield is administered between 6-8 weeks, but not later than stipulated...

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

India has supplied about 60 million Covid-19 vaccine doses to other countries

There was also a mock drill of conducting vaccination and reporting and review meetings at the block, district and state levels. Picture: Hindustan Times

No clotting case in India after Oxford dose

A health department employee counts vials of the vaccine developed by Oxford/AstraZeneca as she prepares to pack them up before they are transported from the state storage to a regional one, during the coronavirus disease (Covid-19) pandemic, in Bhubaneswar, India, January 13, 2021. REUTERS/Danish Siddiqui

Serum India’s Covishield part of Pakistan’s Covid-jab drive under vaccine alliance

A medical worker receives the AstraZeneca's Covishield coronavirus disease (Covid-19) vaccine in Yangon, Myanmar, after the country received 1.5 million doses of the vaccine manufactured by the Serum Institute of India, January 27, 2021. REUTERS/Shwe Paw Mya Tin

Myanmar launches vaccination drive, prioritises frontline healthcare workers

Workers pack syringes at the Hindustan Syringes factory in Faridabad, India on Sept. 2, 2020. SAJJAD HUSSAIN/AFP/GETTY IMAGES

India’s vaccine diplomacy

FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune, India, Nov. 30, 2020. REUTERS/Francis Mascarenhas/File Photo

India, 'pharmacy of the world', starts Covid vaccine exports

FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune, India, Nov. 30, 2020. REUTERS/Francis Mascarenhas/File Photo

Covishield efficacy higher if gap over 28 days, says India’s Serum Institute

Oxford-AstraZeneca's Covid-19 vaccine. Photo: Reuters.

India's Serum to sell AstraZeneca vaccine to Bangladesh at $4/dose

Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus Covid-19" words in this illustration taken April 10, 2020/ Reuters

India's first shipment of Covid vaccine to land at Delhi airport on Thursday night

Covid-19 vaccines approved by India '110% safe' - DCGI chief

Covid-19 vaccines approved by India '110% safe' - DCGI chief

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net